Conference
Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415
Abstract
PURPOSE: The Expanded Prostate Cancer Index Composite (EPIC) is the most commonly used patient reported outcome (PRO) tool in prostate cancer (PC) clinical trials, but health utilities associated with the different health states assessed with this tool are unknown, limiting our ability to perform cost-utility analyses. This study aimed to map EPIC tool to EuroQoL-5D-3L (EQ5D) to generate EQ5D health utilities.
METHODS AND MATERIALS: This is a …
Authors
Khairnar R; Pugh SL; Sandler HM; Lee WR; Olives EV; Mullins CD; Palumbo FB; Bruner DW; Shaya FT; Bentzen SM
Volume
16
Publisher
Public Library of Science (PLoS)
DOI
10.1371/journal.pone.0249123
Conference proceedings
PLOS ONE
Issue
4
ISSN
1932-6203